BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia
10.1186/s12885-018-4661-6
Saved in:
Main Authors: | Zhou Y., Zhou J., Lu X., Tan T.-Z., Chng W.-J. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
BioMed Central Ltd.
2019
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/151673 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7
by: Olivier Goupille, et al.
Published: (2018) -
A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
by: Alisa Damnernsawad, et al.
Published: (2022) -
A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
by: Damnernsawad A.
Published: (2023) -
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
by: Zhou, J, et al.
Published: (2020) -
Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer
by: Zhou, J, et al.
Published: (2021)